(MedPage Today) — The investigational benzamide antipsychotic N-methyl amisulpride (LB-102) led to significant symptom improvement among hospitalized adults with acute schizophrenia, a randomized trial showed.
In this phase II study, the mean…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
